These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6971693)

  • 1. 4-Aminopyridine does not increase m.e.p.p. frequencies at junctions depolarized by potassium.
    van der Kloot W; Madden KS
    Brain Res; 1981 Apr; 210(1-2):467-70. PubMed ID: 6971693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of quantal releases during end-plate currents at the frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1988 Aug; 402():605-26. PubMed ID: 2853224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates].
    Molgó J; Lemeignan M; Peradejordi F; Lechat P
    J Pharmacol; 1985; 16 Suppl 2():109-44. PubMed ID: 2417060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple potassium conductances at the mammalian motor nerve terminal.
    Saint DA; Quastel DM; Guan YY
    Pflugers Arch; 1987 Nov; 410(4-5):408-12. PubMed ID: 2829110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in presynaptic action of 4-aminopyridine and tetraethylammonium at frog neuromuscular junction.
    Glavinović MI
    Can J Physiol Pharmacol; 1987 May; 65(5):747-52. PubMed ID: 2887267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitatory effects of 4-aminopyridine on strontium-mediated evoked and delayed transmitter release from motor nerve terminals.
    Molgó J; Lemeignan M; Guerrero S
    Eur J Pharmacol; 1982 Oct; 84(1-2):1-7. PubMed ID: 6128233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface charges and the effects of calcium on the frequency of miniature end-plate potentials at the frog neuromuscular junction.
    Madden KS; Van der Kloot W
    J Physiol; 1978 Mar; 276():227-32. PubMed ID: 306431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 4-aminopyridine on calcium action potentials and calcium current under voltage clamp in spinal neurons.
    Rogawski MA; Barker JL
    Brain Res; 1983 Nov; 280(1):180-5. PubMed ID: 6652477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.
    Horn AS; Lambert JJ; Marshall IG
    Br J Pharmacol; 1979 Jan; 65(1):53-62. PubMed ID: 216450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How elevated extracellular Ca2+ inhibits quantal acetylcholine release at frog neuromuscular junctions in high K+.
    Van der Kloot W; Latta R
    Pflugers Arch; 1983 Apr; 397(2):85-9. PubMed ID: 6408607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the putative cognitive enhancer, linopirdine (DuP 996), on quantal parameters of acetylcholine release at the frog neuromuscular junction.
    Provan SD; Miyamoto MD
    Br J Pharmacol; 1994 Apr; 111(4):1103-10. PubMed ID: 8032596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interaction of 4-aminopyridine with neostigmine at the neuromuscular junction.
    Tierney PC; Kim YI; Johns TR
    Eur J Pharmacol; 1985 Sep; 115(2-3):241-7. PubMed ID: 2998823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course and magnitude of effects of changes in tonicity on acetylcholine release at frog neuromuscular junction.
    Kita H; van der Kloot W
    J Neurophysiol; 1977 Mar; 40(2):212-24. PubMed ID: 300428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lanthanum as a surrogate for calcium in transmitter release at mouse motor nerve terminals.
    Curtis MJ; Quastel DM; Saint DA
    J Physiol; 1986 Apr; 373():243-60. PubMed ID: 2875177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
    Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
    J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):105-11. PubMed ID: 6245354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.